Concepedia

Dongmin Xu

DX

11

Publications

354

Citations

11

H-Index

2010

Active since

Affiliations

Zhejiang University(Current)

Hamamatsu University School of Medicine

Hangzhou Normal University

University of Hong Kong

National Institute for Physiological Sciences

Dongmin Xu is an author at Zhejiang University specializing in pharmacology, medicine, and inflammation.

Top concepts

MedicinePharmacologyInflammationNeuroinflammationNeurologyCell DeathNeuroscienceNeuroprotectionOxidative StressHealth

Publications per year

2010–2024

11

Publications

11

HAMI 3379, a CysLT2 Receptor Antagonist, Attenuates Ischemia-Like Neuronal Injury by Inhibiting Microglial Activation

Xia-Yan Zhang, Xiaorong Wang, Dongmin Xu et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 57 citations

Cysteinyl leukotriene receptor 1 mediates LTD4-induced activation of mouse microglial cells in vitro

Shu-Ying Yu, Xiayan Zhang, Xiaorong Wang et al. · Acta Pharmacologica Sinica · 2013 · 47 citations · Full text

Inflammation, Cytokine, Mediates Ltd4-induced Activation +13

Enhanced Silicon Anodes with Robust SEI Formation Enabled by Functional Conductive Binder

Benqiang Chen, Dongmin Xu, Simin Chai et al. · Advanced Functional Materials · 2024 · 42 citations

Modified Pedot, Engineering, Electrode-electrolyte Interface +18

Regulation of rotenone-induced microglial activation by 5-lipoxygenase and cysteinyl leukotriene receptor 1

Xiaoyan Zhang, Lu Chen, Yi Yang et al. · Brain Research · 2014 · 41 citations

Inflammation, Oxysterol, Rotenone-induced Microglial Activation +10

Intracerebroventricular injection of HAMI 3379, a selective cysteinyl leukotriene receptor 2 antagonist, protects against acute brain injury after focal cerebral ischemia in rats

Qiaojuan Shi, Li Xiao, Bing Zhao et al. · Brain Research · 2012 · 37 citations

Hami 3379, Pharmacotherapy, Focal Cerebral Ischemia +16

Rows per page

1–5 of 11